Literature DB >> 2872517

Evidence for down-regulation of beta-2-adrenoceptors in cirrhotic patients with severe ascites.

A L Gerbes, J Remien, D Jüngst, T Sauerbruch, G Paumgartner.   

Abstract

The density and affinity of beta-2-adrenoceptors on mononuclear cells from peripheral blood were studied in fifteen patients with cirrhosis of different severity and in thirteen controls. There was no significant difference between cirrhotic patients and controls in density or affinity of beta-2 binding sites. Within the cirrhotic group, however, the number of binding sites per cell was significantly lower in patients with severe ascites than in patients with mild to moderate or no ascites. This down-regulation of beta-adrenoceptors could influence the haemodynamic response to beta-blockers.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2872517     DOI: 10.1016/s0140-6736(86)91556-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  32 in total

1.  Enhanced vascular responses to noradrenaline in isolated omental arteries from patients with advanced cirrhosis: evidence against intrinsic vascular hyporeactivity in cirrhosis.

Authors:  R B Vaughan; P W Angus; J A Angus
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

Review 2.  Clinical pharmacokinetics in patients with liver disease.

Authors:  A J McLean; D J Morgan
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

3.  Origins of cardiac dysfunction in cirrhosis.

Authors:  W Jiménez; V Arroyo
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

Review 4.  Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease.

Authors:  S Møller; J H Henriksen
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

5.  Binding studies of platelet alpha 2- and lymphocyte beta 2-adrenoceptors in patients with cirrhosis.

Authors:  A J MacGilchrist; N M Deighton; C A Hamilton; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

Review 6.  Left ventricular function assessment in cirrhosis: Current methods and future directions.

Authors:  Francisco Sampaio; Joana Pimenta
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 7.  Autonomic dysfunction in chronic liver disease.

Authors:  M T Hendrickse; D R Triger
Journal:  Clin Auton Res       Date:  1993-08       Impact factor: 4.435

Review 8.  Effect of hepatic insufficiency on pharmacokinetics and drug dosing.

Authors:  R K Verbeeck; Y Horsmans
Journal:  Pharm World Sci       Date:  1998-10

9.  Altered adenylyl cyclase activities and G-protein abnormalities in portal hypertensive rabbits.

Authors:  P A Cahill; Y Wu; J V Sitzmann
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 10.  Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.

Authors:  Roger K Verbeeck
Journal:  Eur J Clin Pharmacol       Date:  2008-09-02       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.